Cargando…

Circulating biomarkers during progression to type 1 diabetes: A systematic review

AIM: Progression to type 1 diabetes (T1D) is defined in stages and clinical disease is preceded by a period of silent autoimmunity. Improved prediction of the risk and rate of progression to T1D is needed to reduce the prevalence of diabetic ketoacidosis at presentation as well as for staging partic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brenu, Ekua W., Harris, Mark, Hamilton-Williams, Emma E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9935596/ https://www.ncbi.nlm.nih.gov/pubmed/36817583 http://dx.doi.org/10.3389/fendo.2023.1117076

Ejemplares similares

Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
por: Lamichhane, Santosh, et al.
Publicado: (2023)

The Potential Use of DNA Methylation Biomarkers to Identify Risk and Progression of Type 2 Diabetes
por: Gillberg, Linn, et al.
Publicado: (2015)

Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients
por: Harkin, Carla, et al.
Publicado: (2022)

Progression to type 2 diabetes mellitus after gestational diabetes mellitus diagnosed by IADPSG criteria: Systematic review and meta-analysis
por: Juan, Juan, et al.
Publicado: (2022)

Identification of Neuroendocrine Stress Response-Related Circulating MicroRNAs as Biomarkers for Type 2 Diabetes Mellitus and Insulin Resistance
por: Liang, Ying-Zhi, et al.
Publicado: (2018)

MicroRNA-1281 as a Novel Circulating Biomarker in Patients With Diabetic Retinopathy
por: Greco, Marta, et al.
Publicado: (2020)

Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?
por: Mah, Michael, et al.
Publicado: (2021)

Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Staines, Donald R, et al.
Publicado: (2009)

Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Staines, Donald R, et al.
Publicado: (2009)

Circulating MicroRNAs as Potential Diagnostic Biomarkers for Diabetic Retinopathy: A Meta-Analysis
por: Ma, Lingli, et al.
Publicado: (2022)

Circulating Ism1 Reduces the Risk of Type 2 Diabetes but not Diabetes-Associated NAFLD
por: Wang, Jiajia, et al.
Publicado: (2022)

Editorial: Novel Biomarkers for Type 2 Diabetes
por: Ahluwalia, Tarunveer S., et al.
Publicado: (2019)

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis
por: Johnston, Samantha, et al.
Publicado: (2013)

Profile Screening of Differentially Expressed lncRNAs of Circulating Leukocytes in Type 2 Diabetes Patients and Differences From Type 1 Diabetes
por: Lv, Jianyi, et al.
Publicado: (2022)

The Potential of Metabolomic Analyses as Predictive Biomarkers of Preterm Delivery: A Systematic Review
por: Ronde, Emma, et al.
Publicado: (2021)

Increased Circulating Levels of Ectodysplasin A in Newly Diagnosed Type 2 Diabetic Patients
por: Deng, Xia, et al.
Publicado: (2021)

Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development
por: Bruggeman, Ylke, et al.
Publicado: (2023)

The Relationship Between Circulating Growth Differentiation Factor 15 Levels and Diabetic Retinopathy in Patients With Type 2 Diabetes
por: Niu, Yixin, et al.
Publicado: (2021)

Circulating levels and the bioactivity of miR-30b increase during pubertal progression in boys
por: Mørup, Nina, et al.
Publicado: (2023)

Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity
por: Rautenberg, Emma K., et al.
Publicado: (2022)

Novel biomarkers and therapeutic approaches for diabetic retinopathy and nephropathy: Recent progress and future perspectives
por: Xie, Ziyan, et al.
Publicado: (2022)

Increased Circulation and Adipose Tissue Levels of DNAJC27/RBJ in Obesity and Type 2-Diabetes
por: Cherian, Preethi T., et al.
Publicado: (2018)

Effects of Lifestyle Modification and Anti-diabetic Medicine on Prediabetes Progress: A Systematic Review and Meta-Analysis
por: Sheng, Zhi, et al.
Publicado: (2019)

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
por: Alizadeh, Zeinab, et al.
Publicado: (2022)

Insulin-Like Growth Factor Axis Biomarkers and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Wang, Xi-Rui, et al.
Publicado: (2019)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Relationship Between Type 2 Diabetes and White Matter Hyperintensity: A Systematic Review
por: Wang, Dan-Qiong, et al.
Publicado: (2020)

Gut microbiome and blood glucose control in type 1 diabetes: a systematic review
por: Abuqwider, Jumana, et al.
Publicado: (2023)

Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients’ Age and Disease Duration
por: Arcangeli, Adolfo, et al.
Publicado: (2017)

Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance
por: Alghanim, Ghazi, et al.
Publicado: (2019)

Diabetes health coach in individuals with type 2 diabetes: A systematic review and meta analysis of quadruple aim outcomes
por: Racey, Megan, et al.
Publicado: (2022)

Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes
por: Yip, Linda, et al.
Publicado: (2020)

Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
por: Dejenie, Tadesse Asmamaw, et al.
Publicado: (2023)

The progression of secondary diabetes: A review of modeling studies
por: Yang, Boya, et al.
Publicado: (2022)

Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management
por: Chi, Tiange, et al.
Publicado: (2021)

Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients
por: Yang, Jiaying, et al.
Publicado: (2023)

The efficacy and safety of evogliptin for type 2 diabetes mellitus: A systematic review and meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus
por: Zeng, Haixia, et al.
Publicado: (2022)

Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes
por: Yim, Jisook, et al.
Publicado: (2018)

Circulating MicroRNA-15a Associates With Retinal Damage in Patients With Early Stage Type 2 Diabetes
por: Sangalli, Elena, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_igi9sept8mv1e9630j5vqh0rpm